Canadian CRO Impopharma, which specializes in OINDP analysis and development, has been acquired by Rubicon Research, Rubicon said. Impopharma's Concord, ON facility will become Rubicon's Nasal and Pulmonary Center of Excellence. Impopharma's services included testing and development of nasal sprays, MDIs, and DPIs. According to Rubicon, the company expects the … [Read more...] about Impopharma acquired by Rubicon Research
Products and Services
Nanoform applies for GMP certification
Finnish nanonization specialists Nanoform have filed for GMP certification with the Finnish Medicines Agency (FIMEA), the company said. In December 2018, Nanoform announced construction of a new GMP manufacturing facility in Helsinki. The company, which recently won the the 2019 Excellence in Pharma: Formulation award at CPhI, plans to offer GMP clinical … [Read more...] about Nanoform applies for GMP certification
Recipharm adds SprayView system to OINDP testing facility
CDMO Recipharm has announced an investment of $450,000 for installation of a Proveris Scientific SprayView Measurement System at its facility in Research Triangle Park, North Carolina. The company described the SprayView system as "an important tool that can visualize changes in other critical quality attributes (CQAs) of inhaled and nasal products" and said that it … [Read more...] about Recipharm adds SprayView system to OINDP testing facility
3M Drug Delivery Systems sold to Altaris Capital Partners
3M has announced the sale of "substantially all" of 3M Drug Delivery Systems to Altaris Capital Partners for approximately $650 million. 3M will keep a 17% interest in the new business, which is expected to employ approximately 900 of the current employees after the sale is completed. 3M's inhalation products include standard MDIs, a nasal MDI, and the Intelligent … [Read more...] about 3M Drug Delivery Systems sold to Altaris Capital Partners
Oxford Lasers opens contract aerosol imaging facility
Spray characterization specialists Oxford Lasers have opened a new contract services facility to provide drug delivery device testing at their site in Didcot, UK, the company said. Oxford Lasers Imaging Division Manager Seamus Murphy said, “This marks a new milestone for the Oxford Lasers Imaging division. We have been providing services and systems into the … [Read more...] about Oxford Lasers opens contract aerosol imaging facility
Chiesi announces plans for lower carbon footprint HFA 152a inhaler by the end of 2025
Chiesi announced that the company has signed an agreement with Koura (formerly Mexichem) for supply of HFA 152a propellant as part of a €350 million plan to bring a pMDI with a 90% lower carbon footprint to market by the end of 2025. The company, which has also pledged that it would be carbon neutral by 2035, made the announcement at the Nations Climate Change … [Read more...] about Chiesi announces plans for lower carbon footprint HFA 152a inhaler by the end of 2025
Lupin launches Adhero inhaler monitoring device in India
Lupin has launched its new Adhero connected inhaler monitoring device in India, the company said. According to Lupin, the company collaborated with Aptar Pharma on the device, which attaches to the tops of MDIs. The Adhero sensors allow for monitoring of inhaler use, and data are uploaded to a "MyAdhero" app via Bluetooth. The usage data are also accessible to … [Read more...] about Lupin launches Adhero inhaler monitoring device in India
Hovione Technology completes pilot scale manufacturing for Papillon DPI blisters
Hovione Technology said that the company has completed pilot-scale blister manufacturing and filling for its Papillon dry powder inhaler. The company announced in April 2019 that it had acquired the rights to the DPI from its inventor, Klaus-Dieter Beller. The Papillon DPI, which is formed from a single plastic part and is reusable, can hold doses of up to 50 mg … [Read more...] about Hovione Technology completes pilot scale manufacturing for Papillon DPI blisters
Recipharm to acquire Consort Medical
Swedish CDMO Recipharm has announced that it will acquire Consort Medical, the parent company of device maker Bespak and CDMO Aesica, in order to "Become a Leading Inhalation Company and Top Five Global CDMO Player." According to Recipharm, the companies have agreed on a cash offer of £505 million. In the past few years, Recipharm has aggressively expanded its … [Read more...] about Recipharm to acquire Consort Medical
Biocorp announces deal with Vitrobio for manufacturing of intranasal product
French drug delivery device company Biocorp announced that it has entered into a 10-year strategic partnership with Vitrobio Pharma regarding manufacturing of a new intranasal polymeric product that the company says "acts as a barrier on the nasal surface and prevents contact with pollutants and allergens, while eliminating histamines and harmful proteins through … [Read more...] about Biocorp announces deal with Vitrobio for manufacturing of intranasal product